Over the past decade, autoimmune diseases have remained one of the most stable and high-growth areas in global drug innovation. From TNF-α inhibitors to IL-17/IL-23

China’s pharmaceutical industry is undergoing a profound structural transformation, and China pharmaceutical export trends are also changing significantly. From a past dominated by active pharmaceutical

In recent years, GLP-1 receptor agonists (GLP-1 RAs) have become one of the most closely watched therapeutic areas in the global metabolic disease landscape. Among

Breast cancer is the most common malignancy among women worldwide, with incidence continuing to rise. Precision molecular subtyping and individualized therapies have improved outcomes, but

The landscape of approved cell and gene therapy drugs in China is rapidly evolving, as these advanced treatment approaches are increasingly recognized worldwide for their

Currently, africa pharmaceutical industry challenges are increasingly recognized as a key issue in the global healthcare supply system. These challenges extend beyond drug access and

With the continuous restructuring of the global healthcare supply chain, China has become one of the most important sources of international pharmaceutical procurement. An increasing